Product Information
ARMODAFINIL 250 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.9082 per EA under NDC 65862080730. Its NADAC has been published 408 times since Dec 12, 2018.
FDA first approved this application on Mar 6, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862080730
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARMODAFINILApproval Type
Generic (ANDA)
FDA Application
ANDA206069FDA Approved
3/6/2018
TE Code
AB
On Market Since
3/6/2018
Price Statistics
The NADAC for ARMODAFINIL 250 MG TABLET has been published 408 times since Dec 12, 2018, and over the history we have for it it has declined 27.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9082 per EA |
|---|---|
| All-time high | $1.2947 (Sep 15, 2021) |
| All-time low | $0.6325 (Nov 20, 2024) |
| 52-week high | $0.9673 |
| 52-week low | $0.9011 |
| Median price | $0.9352 |
| Average price | $0.9768 |
| Largest weekly change | +32.0% (Aug 23, 2023) |
| Weeks tracked | 408 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Armodafinil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARMODAFINIL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARMODAFINIL 250 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.9082 per EA (NDC 65862080730), effective Sep 30, 2026.
How has the price of ARMODAFINIL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARMODAFINIL 250 MG TABLET has declined 27.7%. It has been tracked across 408 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for ARMODAFINIL 250 MG TABLET?
Since Dec 12, 2018, the NADAC for ARMODAFINIL 250 MG TABLET has ranged from a low of $0.6325 (Nov 20, 2024) to a high of $1.2947 (Sep 15, 2021), with a median of $0.9352 per EA.
Are there cheaper alternatives to ARMODAFINIL 250 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARMODAFINIL 250 MG TABLET, is $0.8651 per EA — about 5% below ARMODAFINIL 250 MG TABLET.
Who manufactures ARMODAFINIL 250 MG TABLET?
ARMODAFINIL 250 MG TABLET (NDC 65862080730) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.